Del C. Lopez-Asensio
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
miR-106b-5p as a Central Regulator of Cancer Progression and Chemotherapy-Induced Cardiotoxicity: From Molecular Mechanisms to Clinical Translation.
Journal: International journal of molecular sciences
Published: July 04, 2025
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings.
Journal: Frontiers in pharmacology
Published: April 07, 2025
AEOL-induced NRF2 activation and DWORF overexpression mitigate myocardial I/R injury.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 29, 2024
AEOL-induced NRF2 activation and DWORF overexpression mitigate myocardial I/R injury.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 29, 2024
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis.
Journal: Molecular therapy. Nucleic acids
Published: September 15, 2022
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
Journal: Scientific reports
Published: April 13, 2020
Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: November 06, 2017
Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers.
Journal: European journal of clinical investigation
Published: January 15, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026